Surajit Pal of Prabhudas Lilladher said the brokerage will not be taking price action for pharma stocks. It will be difficult to prove the charges of price collusion, he added.
first published: Nov 4, 2016 10:28 am
A collection of the most-viewed Moneycontrol videos.

This Tenant says Andheri West is better than SOBO | The tenant

Nifty Clocks Second Week Of Gains But Still Awaits New Peak;Midcaps Snap 7-Week Run|Closing Bell

Will Nifty Bulls March Towards Fresh Peak Despite Dismal Global Cues? | Opening Bell Live

Nifty Aims For Next 26,100 After Hitting 3-Week High |Opening Bell Live
You are already a Moneycontrol Pro user.

